Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.

Frontiers in immunology - 1 Jan 2022

Hashem Hasan, Dimitrova Dimana, Meyts Isabelle

Abstract excerpt

Deficiency of adenosine deaminase 2 (DADA2) is an inherited autosomal recessive disease characterized by autoinflammation (recurrent fever), vasculopathy (livedo racemosa, polyarteritis nodosa, lacunar ischemic strokes, and intracranial hemorrhages, end organ vasculitis), immunodeficiency, lymphoproliferation, immune cytopenias, and bone marrow failure. Allogeneic hematopoietic cell transplantation (HCT) is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Deaminase
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Deficiency Syndromes

Share to Intercellular Signaling Peptides and Proteins

Share to Mutation

Share to Vasculitis

Source

Open in PubMed Open full text

Identifiers

PMID: 35911698
DOI: 10.3389/fimmu.2022.932385
PMCID: PMC9336546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations.PMID 35911698Read ↗

Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.Semantic proximity Read ↗

Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.Semantic proximity Read ↗

Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.Semantic proximity Read ↗

Deficiency of adenosine deaminase 2 (DADA2): Review.Semantic proximity Read ↗

The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.Semantic proximity Read ↗

Human adenosine deaminase 2 deficiency: A multi‐faceted inborn error of immunitySemantic proximity Read ↗

DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.Semantic proximity Read ↗

Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitisSemantic proximity Read ↗

Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.Semantic proximity Read ↗

Treatment and Outcome in Deficiency of Adenosine Deaminase 2: A Literature Review.Semantic proximity Read ↗

Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement.Semantic proximity Read ↗

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.